Hacker News

GLP-1 may slow biological aging

uc-san-diego-glp-1

June 11, 2026Susanne Clara Bard, UC San Diego Semaglutide, a widely used weight loss drug sometimes sold as Ozempic or Wegovy, slowed biological aging across multiple epigenetic clocks in a randomized, double-blind, placebo-controlled clinical trial. Credit: iStock/Eduardo Monroy Husillos Key takeaways UC San Diego is leading the way in exploring whether popular GLP-1 drugs consisting of semaglutide — like Ozempic and Wegovy — can slow biological aging. Their new federally funded study provides the first randomized, placebo-controlled clinical evidence of their possible age-slowing effects. Beyond the widespread attention GLP-1 drugs are receiving for treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease, emerging research is…

Continue reading at Hacker News universityofcalifornia.edu
Advertisement